CClinicalTrials.gg
CompletedNCT05020808Updated Jun 22, 2022

The Effect of a Plant Protein Isolate on Muscle Protein Synthesis in Humans at Rest and After Resistance Exercise

An interventional study of NEAA and PPI in Metabolism, Exercise and Dietary Supplements, sponsored by University of Limerick. Completed at 1 site in Ireland. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-06-22.

Sponsored by University of Limerick · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

Plant-based proteins contain several amino acids that are essential to signal growth, reconditioning, maintenance and preservation of skeletal muscle mass. This study aims to inform on the nutrient activation of muscle protein synthesis (MPS) by feeding a plant protein isolate equivalent to 0.33 g of protein per kilogram of body mass.

Read the detailed description

Participants: 32 young, healthy men and women aged 18 - 35 years. Intervention: Plant protein isolate (PPI) and nonessential amino acid control (NEAA) Study Design: Block randomised control trial. Two group parallel design. Primary outcome: Myofibrillar fractional synthetic rate (myoFSR).

Preliminary screening/familiarization consists of: medical history, dietary assessment and examination by a medical doctor and a qualified dietician, blood sample to be evaluated for health-related contraindications, body composition measurement by dual energy x-ray absorptiometry (DXA), isokinetic knee extensor strength tests.

Pre-trial: A metered dose of deuterium oxide (5ml/kg) will be ingested and blood and/or saliva (\~5ml) samples will be collected pre/post ingestion.

Experimental trial: Blood, saliva and bilateral m.vastus lateralis microbiopsies (\~100 mg) collected. A unilateral resistance-training session consisting of knee extensor contractions will be completed. Following exercise cessation participants will ingest 0.33 g/kg body mass of either: a nonessential amino acid formulation or a plant-protein isolate. A saliva sample and a 2nd set of bilateral m.vastus lateralis microbiopsies are collected 3 h postingestion.

02

Conditions studied

  • Metabolism
  • Exercise
  • Dietary Supplements

Keywords

  • amino acids
  • deuterium oxide
  • humans
  • protein synthesis
  • plant proteins
  • resistance training
  • skeletal muscle
03

In context

Lead sponsor

University of Limerick is the lead sponsor of 56 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Men and women aged 18 to 35 years

Exclusion criteria

Exclusion Criteria:

  • Known intolerance to any item contained in the protein products.
  • Blood borne disease risk, current illness or medication that would adversely affect participation
  • Known adverse reaction to venepuncture and/or biopsy
  • Inability to undertake resistance exercise
  • Inability to adhere to protocol guidelines
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
33 participants (actual)

Study arms

  • Sham comparator
    Nonessential amino acid formulation (NEAA)

    Novel non-essential amino acid blend dosed at 0.33 g/kg body mass in 400 ml of water. Postprandial muscle protein synthesis at rest, and after resistance exercise to be measured by deuterium incorporation in to skeletal muscle sampled by bilateral microbiopsies. Product Number: NEAA56812

    Dietary Supplement: NEAA

  • Active comparator
    Plant Protein Isolate (PPI)

    Plant protein isolate (Fava bean) dosed at 0.33 g/kg body mass in 400 ml of water. Postprandial muscle protein synthesis at rest, and after resistance exercise to be measured by deuterium incorporation in to skeletal muscle sampled by bilateral microbiopsies. Product Number: FP2011273

    Dietary Supplement: PPI

Interventions

  • Dietary supplementNEAA

    Food grade mixture of non-essential amino acids in powdered form to be dissolved in water. Supplied by Marigot Ltd, Cork, Ireland

  • Dietary supplementPPI

    Food grade plant (legume - Fava) protein isolate to be dissolved in water. Supplied by Marigot Ltd, Cork, Ireland

    Also known as: Plant Protein Isolate

06

What researchers measure

Primary outcomes

  1. Myofibrillar fractional synthetic rate change

    The fractional rate of myofibrillar protein synthesis measured by deuterium incorporation into skeletal muscle sampled by microbiopsy

    Time frame: 4 hours

07

Study locations

1 site
  • University of Limerick
    Limerick, Munster V94 T9PX, Ireland
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 22, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05020808
Lead sponsor
University of Limerick
Collaborators
Marigot Ltd., Enterprise Ireland
Responsible party
Robert Davies (Principal Investigator, University of Limerick) — Principal investigator
First posted
Aug 25, 2021
Start date
Sep 14, 2021
Primary completion
Jun 20, 2022
Completion
Jun 20, 2022
Last update
Jun 22, 2022

Study contacts

Philip M Jakeman, PhD
principal investigator · University of Limerick
Robert W Davies, PhD
principal investigator · University of Limerick

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion